John H. Johnson

John H. Johnson is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone, and Pfizer, Inc. He currently serves as the Chairman of the Board of Autolus Therapeutics as well as a member of the board of directors of Verastem, Inc., and Axogen, Inc. Mr. Johnson previously served as Chief Executive Officer of Strongbridge BioPharma as well as a member of its Board of Directors until its acquisition by Xeris. He also served on the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ. Mr. Johnson holds a BS from the East Stroudsburg University of Pennsylvania.